This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Melby, P. C.
Right arrow Articles by Freeman, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Melby, P. C.
Right arrow Articles by Freeman, G. L.

 Previous Article  |  Next Article 

Infect Immun, May 1998, p. 2135-2142, Vol. 66, No. 5
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Cloning of Syrian Hamster (Mesocricetus auratus) Cytokine cDNAs and Analysis of Cytokine mRNA Expression in Experimental Visceral Leishmaniasis

Peter C. Melby,1,2,3,* Victor V. Tryon,2 Bysani Chandrasekar,3 and Gregory L. Freeman1,3

Medical Service, Department of Veterans Affairs Medical Center,1 and Department of Medicine3 and Department of Microbiology,2 The University of Texas Health Science Center, San Antonio, Texas

Received 20 November 1997/Returned for modification 11 January 1998/Accepted 12 February 1998

The Syrian golden hamster (Mesocricetus auratus) is uniquely susceptible to a variety of intracellular pathogens and is an excellent model for a number of human infectious diseases. The molecular basis for this high level of susceptibility is unknown, and immunological studies related to this model have been limited by the lack of available reagents. In this report we describe the cloning and sequence analysis of portions of the Syrian hamster interleukin 2 (IL-2), IL-4, gamma interferon (IFN-gamma ), tumor necrosis factor alpha, IL-10, IL-12p40, and transforming growth factor beta  cDNAs. In addition, we examined the cytokine response to infection with the intracellular protozoan Leishmania donovani in this animal model. Sequence analysis of the hamster cytokines revealed 69 to 93% homology with the corresponding mouse, rat, and human nucleotide sequences and 48 to 100% homology with the deduced amino acid sequences. The hamster IFN-gamma , compared with the mouse and rat homologs, had an additional 17 amino acids at the C terminus that could decrease the biological activity of this molecule and thus contribute to the extreme susceptibility of this animal to intracellular pathogens. The splenic expression of these genes in response to infection with L. donovani, the cause of visceral leishmaniasis (VL), was determined by Northern blotting. VL in the hamster is a progressive, lethal disease which very closely mimics active human disease. In this model there was pronounced expression of the Th1 cytokine mRNAs, with transcripts being detected as early as 1 week postinfection. Basal expression of IL-4 in uninfected hamsters was prominent but did not increase in response to infection with L. donovani. IL-12 transcript expression was detected at low levels in infected animals and paralleled the expression of IFN-gamma . Expression of IL-10, a potent macrophage deactivator, increased throughout the course of infection and could contribute to the progressive nature of this infection. These initial studies are the first to examine the molecular immunopathogenesis of a hamster model of VL infection and indicate that progressive disease in this model of VL is not associated with early polarization of the splenic cellular immune response toward a Th2 phenotype and away from a Th1 phenotype.

* Corresponding author. Mailing address: Department of Medicine, Division of Infectious Diseases, The University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78284-7881. Phone: (210) 567-4823. Fax: (210) 567-4670. E-mail: melby{at}uthscsa.edu.

Infect Immun, May 1998, p. 2135-2142, Vol. 66, No. 5
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Samant, M., Gupta, R., Kumari, S., Misra, P., Khare, P., Kushawaha, P. K., Sahasrabuddhe, A. A., Dube, A. (2009). Immunization with the DNA-Encoding N-Terminal Domain of Proteophosphoglycan of Leishmania donovani Generates Th1-Type Immunoprotective Response against Experimental Visceral Leishmaniasis. J. Immunol. 183: 470-479 [Abstract] [Full Text]  
  • Banerjee, S., Ghosh, J., Sen, S., Guha, R., Dhar, R., Ghosh, M., Datta, S., Raychaudhury, B., Naskar, K., Haldar, A. K., Lal, C. S., Pandey, K., Das, V. N. R., Das, P., Roy, S. (2009). Designing Therapies against Experimental Visceral Leishmaniasis by Modulating the Membrane Fluidity of Antigen-Presenting Cells. Infect. Immun. 77: 2330-2342 [Abstract] [Full Text]  
  • Mongue-Din, H., Salmon, A., Fiszman, M. Y., Fromes, Y. (2009). Periodic variation in R-R intervals and cardiovascular autonomic regulation in young adult Syrian hamsters. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296: R610-R617 [Abstract] [Full Text]  
  • Banerjee, A., De, M., Ali, N. (2008). Complete Cure of Experimental Visceral Leishmaniasis with Amphotericin B in Stearylamine-Bearing Cationic Liposomes Involves Down-Regulation of IL-10 and Favorable T Cell Responses. J. Immunol. 181: 1386-1398 [Abstract] [Full Text]  
  • Osorio, Y., Bonilla, D. L., Peniche, A. G., Melby, P. C., Travi, B. L. (2008). Pregnancy enhances the innate immune response in experimental cutaneous leishmaniasis through hormone-modulated nitric oxide production. J. Leukoc. Biol. 83: 1413-1422 [Abstract] [Full Text]  
  • Vernel-Pauillac, F., Merien, F. (2006). Proinflammatory and Immunomodulatory Cytokine mRNA Time Course Profiles in Hamsters Infected with a Virulent Variant of Leptospira interrogans. Infect. Immun. 74: 4172-4179 [Abstract] [Full Text]  
  • Perez, L. E., Chandrasekar, B., Saldarriaga, O. A., Zhao, W., Arteaga, L. T., Travi, B. L., Melby, P. C. (2006). Reduced Nitric Oxide Synthase 2 (NOS2) Promoter Activity in the Syrian Hamster Renders the Animal Functionally Deficient in NOS2 Activity and Unable to Control an Intracellular Pathogen. J. Immunol. 176: 5519-5528 [Abstract] [Full Text]  
  • Rama Iniguez, S., Dea-Ayuela, M. A., Sanchez-Brunete, J. A., Torrado, J. J., Alunda, J. M., Bolas-Fernandez, F. (2006). Real-Time Reverse Transcription-PCR Quantification of Cytokine mRNA Expression in Golden Syrian Hamster Infected with Leishmania infantum and Treated with a New Amphotericin B Formulation.. Antimicrob. Agents Chemother. 50: 1195-1201 [Abstract] [Full Text]  
  • Ukil, A., Biswas, A., Das, T., Das, P. K. (2005). 18{beta}-Glycyrrhetinic Acid Triggers Curative Th1 Response and Nitric Oxide Up-Regulation in Experimental Visceral Leishmaniasis Associated with the Activation of NF-{kappa}B. J. Immunol. 175: 1161-1169 [Abstract] [Full Text]  
  • Mendez, S., Valenzuela, J. G., Wu, W., Hotez, P. J. (2005). Host Cytokine Production, Lymphoproliferation, and Antibody Responses during the Course of Ancylostoma ceylanicum Infection in the Golden Syrian Hamster. Infect. Immun. 73: 3402-3407 [Abstract] [Full Text]  
  • Basu, R., Bhaumik, S., Basu, J. M., Naskar, K., De, T., Roy, S. (2005). Kinetoplastid Membrane Protein-11 DNA Vaccination Induces Complete Protection against Both Pentavalent Antimonial-Sensitive and -Resistant Strains of Leishmania donovani That Correlates with Inducible Nitric Oxide Synthase Activity and IL-4 Generation: Evidence for Mixed Th1- and Th2-Like Responses in Visceral Leishmaniasis. J. Immunol. 174: 7160-7171 [Abstract] [Full Text]  
  • Mookerjee, A., Sen, P. C., Ghose, A. C. (2003). Immunosuppression in Hamsters with Progressive Visceral Leishmaniasis Is Associated with an Impairment of Protein Kinase C Activity in Their Lymphocytes That Can Be Partially Reversed by Okadaic Acid or Anti-Transforming Growth Factor {beta} Antibody. Infect. Immun. 71: 2439-2446 [Abstract] [Full Text]  
  • Murray, H. W., Lu, C. M., Mauze, S., Freeman, S., Moreira, A. L., Kaplan, G., Coffman, R. L. (2002). Interleukin-10 (IL-10) in Experimental Visceral Leishmaniasis and IL-10 Receptor Blockade as Immunotherapy. Infect. Immun. 70: 6284-6293 [Abstract] [Full Text]  
  • Travi, B. L., Osorio, Y., Melby, P. C., Chandrasekar, B., Arteaga, L., Saravia, N. G. (2002). Gender Is a Major Determinant of the Clinical Evolution and Immune Response in Hamsters Infected with Leishmania spp.. Infect. Immun. 70: 2288-2296 [Abstract] [Full Text]  
  • Murray, H. W. (2001). Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis. Antimicrob. Agents Chemother. 45: 2185-2197 [Full Text]  
  • Das, L., Datta, N., Bandyopadhyay, S., Das, P. K. (2001). Successful Therapy of Lethal Murine Visceral Leishmaniasis with Cystatin Involves Up-Regulation of Nitric Oxide and a Favorable T Cell Response. J. Immunol. 166: 4020-4028 [Abstract] [Full Text]  
  • Melby, P. C., Chandrasekar, B., Zhao, W., Coe, J. E. (2001). The Hamster as a Model of Human Visceral Leishmaniasis: Progressive Disease and Impaired Generation of Nitric Oxide in the Face of a Prominent Th1-Like Cytokine Response. J. Immunol. 166: 1912-1920 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»